NCT06288334View on ClinicalTrials.gov

Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children

PHASE4RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 6, 2020

Primary Completion Date

March 31, 2024

Study Completion Date

May 31, 2024

Conditions
Allergic DiseaseChildren
Interventions
OTHER

1-3 Cetirizine Pharmacokinetic samples

Limited sampling strategy was used in this study. For each child, only 1\~3 blood samples were collected before and after cetirizine administration.

Trial Locations (1)

100191

RECRUITING

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER